~~<i id='71666C240A'><strike id='71666C240A'><tt id='71666C240A'><pre id='71666C240A'></pre></tt></strike></i>~~

Home» leisure time» hotspot

hotspot

author：knowledge 2025-10-09 07:57:21 Page View：1283

Introducing STAT’s Biotech Q2 Scorecard, our emoji-enabled means of tracking 12 make-or-break events expected over the next three months.

When each clinical trial or FDA decision crosses the wires, we’ll add in the appropriate rocket ship, grimace face, bulging bicep or broken heart — whatever captures the mood.

Read on for brief explanations of what we’re watching for from each company.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virtual Event: March of the Biosimilars
Next article： State Dept. review finds Biden bears some blame for Afghanistan failures

explore

Peter Hotez and the public health issue of online harassment

AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

Nevada Republican Sam Brown launching another Senate bid, teeing up marquee race

1:27RepublicanSenatecandidate,retiredArmyCapt.SamBrown,thankssupporterswhilewaitingforelectionresult

Affirmative action in medical school literally saved lives

AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

Medicare wants to send $9 billion to 340B hospitals

Medicareisplanningtosend$9billioninlumpsumpaymentstomorethan1,600hospitalsthatparticipateinadrugdisc